METTL3 and ovarian cancer: METTL3 can recognize the m6A modification of pri-miR-1246, and thus upregulate the expression of miR-1246, which inhibited CCNG2 to accelerate cell proliferation, migration, and invasion, but suppressed apoptosis of ovarian cancer cells, with the net effect of promoting the progression of ovarian cancer.